Brian M. Clancy

pushing #precisiononcology forward w #RWE at @foundationatcg . #digitalhealth person.

[Brian M. Clancy @bclan13]

Had a blast sharing our framework Defining Fit-For-Purpose Real-World Evidence (#RWE) for Supporting CDx Approvals at #WorldCDx @WorldCDx today - thanks for the great audience!

#PrecisionOncology #RWD

[Brian M. Clancy @bclan13]

@zachweinberg have you read “abundance” yet?

[Brian M. Clancy @bclan13]

@cwhogg embrace neuro diversity

[Brian M. Clancy @bclan13]

“We’re proud to provide our high-quality tissue-based genomic test, along with real-world data from our Flatiron Health-Foundation Medicine Clinico-Genomic Database, to support PMV Pharma as they develop this exciting new treatment option.”

#ASCO24 #CGDB https://t.co/MFt4mnb7qq

[Brian M. Clancy @bclan13]

—>

[Foundation Medicine @FoundationATCG]

We're working w/@flatironhealth to introduce a novel capability for supporting CDx filings using real-world data from the Flatiron Health-Foundation Medicine Clinico-Genomic Database (CGDB) as supportive clinical evidence for regulatory filings for precision oncology CDxs.

[Brian M. Clancy @bclan13]

We are working with @flatironhealth to introduce a novel capability for supporting companion diagnostic regulatory filings!

Read more about the benefits of this capability in a new @GenomeWeb article.

#PrecisionOncology #esmo #esmo23 #esmo2023 #RWD

https://t.co/2NjRvrSrOP

[Brian M. Clancy @bclan13]

What a haul! #talent

[Adrian Wojnarowski @wojespn]

Final tally on Lillard trade: Portland gets Deandre Ayton, Robert Williams, Malcolm Brogdon, Toumani Camara, three first-round picks 2024 (Golden State, Top-4 protected), 2029 (Bucks and Celtics unprotected) and 2028 and 2030 Milwaukee pick swaps.

[The Evidence Base @TheEviBase]

Brian Clancy from @FoundationATCG discusses the evolving role of #realworlddata to complement traditional evidence generation in #precisionmedicine and how #realworldevidence can be used in the approval of #companiondiagnostics.

Read here >> https://t.co/vVN4OEOL6H

[Brian M. Clancy @bclan13]

Thanks to @TheEviBase for hosting this important conversation on the potential for fit for purpose RWE in supporting companion diagnostics approvals

And thanks to many colleagues at @FoundationATCG in informing our perspective here!

[The Evidence Base @TheEviBase]

Brian Clancy from @FoundationATCG discusses the evolving role of #realworlddata to complement traditional evidence generation in #precisionmedicine and how #realworldevidence can be used in the approval of #companiondiagnostics.

Read here >> https://t.co/vVN4OEOL6H

[Celtics Junkies @Celtics_Junkies]

Jaylen Brown and Jayson Tatum together as teenagers (2014)

It was always meant to be 🔥☘️

[Brad Schnure @schnure]

After waiting weeks for a treatment plan, I started today on Alecensa (alectinib), which is a targeted therapy for "ALK positive" lung cancer.

I lucked out that biomarker testing came back positive for a rare mutation for which there are some extremely effective drugs available. That mutation is almost certainly what caused my cancer in the first place.

For now, at least, that means no chemotherapy. I'll just be taking a bunch of pills several times a day.

According to my oncologist, this drug starts working within a day or two and literally melts the cancer away. That's good because the PET scan I got last week showed the cancer was in more places than initially thought.

The drug works for an average of two years for patients, but some get years more from it. There are a few other options to try when it stops working, which eventually will happen.

About 50% of ALK positive patients live to seven years after diagnosis. That's a hell of a lot better than the 7% chance of making it to five years that I was initially given, with the likelihood that my horizon could be significantly shorter based on the advanced nature of my disease.

In short, my timeline likely just got extended from weeks or months to possibly years. Hopefully, those will be good quality years that will give me the chance to see my kids grow up and be part of their lives. I'm beyond thankful for that opportunity.

[Geoff Oxnard MD @geoff_oxnard]

Flatiron is honored to continue our collaboration with FDA https://t.co/mJIxbVoNZk

[Brian M. Clancy @bclan13]

Recent events had me trying to determine what fudge rounds are and whether or not they are funded by tax dollars

[Brian M. Clancy @bclan13]

New paper teasing apart disparities in prostate cancer leveraging #cgdb

#dia2023 https://t.co/Ek3s8pV1bI

[Brian M. Clancy @bclan13]

@anothercohen Strongly worded!

[𝐃𝐚𝐦𝐚𝐫 𝐇𝐚𝐦𝐥𝐢𝐧 @HamlinIsland]

GameDay.. Nothing I Want More Than To Be Running Out That Tunnel With My Brothers. God Using Me In A Different Way Today. Tell Someone You Love Them Today! 🫶🏾3️⃣ let’s go @BuffaloBills ❤️💙

[Brian M. Clancy @bclan13]

Important research at #ESMO22 leveraging the Flatiron Health - Foundation Medicine CGDB. Congrats to the authors! @Huntsman_GU @huntsmancancer

[Rana McKay, MD, FASCO @DrRanaMcKay]

With @umangtalking @neerajaiims at the #ESMO22 poster session 👉Congrats for the GU Best poster award. Always amazing research from @Huntsman_GU team. @OncoAlert @urotoday @huntsmancancer

[Rana McKay, MD, FASCO @DrRanaMcKay]

With @umangtalking @neerajaiims at the #ESMO22 poster session 👉Congrats for the GU Best poster award. Always amazing research from @Huntsman_GU team. @OncoAlert @urotoday @huntsmancancer

[Brian M. Clancy @bclan13]

Now you can see our latest #product opening on our Genomics #RWD team while scrolling healthcare meme scrolling on Out of Pocket :)

#precisiononcology #genomics #data https://t.co/scIbc7IdvV

[Brian M. Clancy @bclan13]

@cwhogg does that mean you are changing your biz model from B2C2B to B2B? :)